160 related articles for article (PubMed ID: 11460842)
21. The impact of baseline left ventricular size and mitral regurgitation on reverse left ventricular remodelling in response to carvedilol: size doesn't matter.
Kotlyar E; Hayward CS; Keogh AM; Feneley M; Macdonald PS
Heart; 2004 Jul; 90(7):800-1. PubMed ID: 15201254
[No Abstract] [Full Text] [Related]
22. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
Lee YC
Am J Cardiol; 1997 Apr; 79(7):1001. PubMed ID: 9104927
[No Abstract] [Full Text] [Related]
23. Doxorubicin-induced cardiomyopathy treated with carvedilol.
Fazio S; Palmieri EA; Ferravante B; Bonè F; Biondi B; Saccà L
Clin Cardiol; 1998 Oct; 21(10):777-9. PubMed ID: 9789703
[TBL] [Abstract][Full Text] [Related]
24. Prospective single-arm protocol of carvedilol in children with ventricular dysfunction.
Blume ED; Canter CE; Spicer R; Gauvreau K; Colan S; Jenkins KJ
Pediatr Cardiol; 2006; 27(3):336-42. PubMed ID: 16596434
[TBL] [Abstract][Full Text] [Related]
25. Carvedilol in children with cardiomyopathy: 3-year experience at a single institution.
Rusconi P; Gómez-Marín O; Rossique-González M; Redha E; Marín JR; Lon-Young M; Wolff GS
J Heart Lung Transplant; 2004 Jul; 23(7):832-8. PubMed ID: 15261177
[TBL] [Abstract][Full Text] [Related]
26. Electrophysiological effects of carvedilol administration in patients with dilated cardiomyopathy.
Kanoupakis EM; Manios EG; Mavrakis HE; Kallergis EM; Lyrarakis GM; Koutalas EP; Vardas PE
Cardiovasc Drugs Ther; 2008 Jun; 22(3):169-76. PubMed ID: 18205033
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of carvedilol to abolish myocardial postsystolic shortening in patients with idiopathic dilated cardiomyopathy.
Ito T; Kawanishi Y; Futai R; Terasaki F; Kitaura Y
Am J Cardiol; 2009 Dec; 104(11):1568-73. PubMed ID: 19932794
[TBL] [Abstract][Full Text] [Related]
28. Intractable recurrent ventricular tachycardia in dilated cardiomyopathy controlled by a vasodilating beta blocker.
Wright DJ; Cooke GA; Tan LB
Heart; 1997 Jun; 77(6):581-2. PubMed ID: 9227309
[No Abstract] [Full Text] [Related]
29. Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine.
Gerson MC; Craft LL; McGuire N; Suresh DP; Abraham WT; Wagoner LE
J Nucl Cardiol; 2002; 9(6):608-15. PubMed ID: 12466785
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of beta-blockers on left ventricular dyssynchrony and reverse remodeling in idiopathic dilated cardiomyopathy: A randomized trial of carvedilol and metoprolol.
Kaya MG; Sarli B; Akpek M; Kaya EG; Yarlioglues M; Topsakal R; Lam YY
Cardiol J; 2014; 21(4):434-41. PubMed ID: 24142686
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
Eur Heart J; 2007 Apr; 28(8):989-95. PubMed ID: 17409109
[TBL] [Abstract][Full Text] [Related]
32. Relation of early improvement in coronary flow reserve to late recovery of left ventricular function after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
Sugioka K; Hozumi T; Takemoto Y; Ehara S; Ogawa K; Iwata S; Oe H; Matsumura Y; Otsuka R; Yoshiyama M; Yoshikawa J
Am Heart J; 2007 Jun; 153(6):1080.e1-6. PubMed ID: 17540213
[TBL] [Abstract][Full Text] [Related]
33. Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study.
Bellenger NG; Rajappan K; Rahman SL; Lahiri A; Raval U; Webster J; Murray GD; Coats AJ; Cleland JG; Pennell DJ;
Heart; 2004 Jul; 90(7):760-4. PubMed ID: 15201244
[TBL] [Abstract][Full Text] [Related]
34. Modulation of neurohormonal activity after treatment of children in heart failure with carvedilol.
Giardini A; Formigari R; Bronzetti G; Prandstraller D; Donti A; Bonvicini M; Picchio FM
Cardiol Young; 2003 Aug; 13(4):333-6. PubMed ID: 14694952
[TBL] [Abstract][Full Text] [Related]
35. What type of beta-blocker should be used to treat chronic heart failure?
Bristow MR
Circulation; 2000 Aug; 102(5):484-6. PubMed ID: 10920055
[No Abstract] [Full Text] [Related]
36. The effect of carvedilol therapy on coronary flow reserve in patients with idiopathic dilated cardiomyopathy.
Calişkan M; Ciftçi O; Güllü H; Müderrisoğlu H
Turk Kardiyol Dern Ars; 2008 Jun; 36(4):247-52. PubMed ID: 18765968
[TBL] [Abstract][Full Text] [Related]
37. Effects of carvedilol in heart failure due to dilated cardiomyopathy. Results of a double-blind randomized placebo-controlled study (CARIBE study).
Chizzola PR; Freitas HF; Caldas MA; da Costa JM; Meneghetti C; Marinho NV; Mansur AJ; Ramires JA; Bocchi EA
Arq Bras Cardiol; 2000 Mar; 74(3):233-42. PubMed ID: 10951826
[TBL] [Abstract][Full Text] [Related]
38. Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy.
Kurum T; Tatli E; Yuksel M
Tex Heart Inst J; 2007; 34(1):52-9. PubMed ID: 17420794
[TBL] [Abstract][Full Text] [Related]
39. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
Razzolini R; Tarantini G; Boffa GM; Orlando S; Iliceto S
Ital Heart J; 2004 Jul; 5(7):517-22. PubMed ID: 15487269
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.
Rhodes J; Margossian R; Darras BT; Colan SD; Jenkins KJ; Geva T; Powell AJ
Pediatr Cardiol; 2008 Mar; 29(2):343-51. PubMed ID: 17885779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
